Journal articles on the topic 'Defibrotide'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Defibrotide.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Richardson, Paul G., Marta Palomo, Nancy A. Kernan, Gerhard C. Hildebrandt, Nelson Chao, and Enric Carreras. "The importance of endothelial protection: the emerging role of defibrotide in reversing endothelial injury and its sequelae." Bone Marrow Transplantation 56, no. 12 (September 28, 2021): 2889–96. http://dx.doi.org/10.1038/s41409-021-01383-x.
Full text&NA;. "Defibrotide." Reactions Weekly &NA;, no. 538 (February 1995): 7. http://dx.doi.org/10.2165/00128415-199505380-00024.
Full textPalmer, Katharine J., and Karen L. Goa. "Defibrotide." Drugs 45, no. 2 (February 1993): 259–94. http://dx.doi.org/10.2165/00003495-199345020-00007.
Full text&NA;. "Defibrotide." Reactions Weekly &NA;, no. 1113 (August 2006): 9. http://dx.doi.org/10.2165/00128415-200611130-00028.
Full textCoccheri, Sergio, and Giovanna Biagi. "Defibrotide." Cardiovascular Drug Reviews 9, no. 2 (June 1991): 172–96. http://dx.doi.org/10.1111/j.1527-3466.1991.tb00410.x.
Full textMoore, Julie M., and John W. Avery. "Defibrotide." Arteriosclerosis, Thrombosis, and Vascular Biology 32, no. 3 (March 2012): 541–44. http://dx.doi.org/10.1161/atvbaha.111.242776.
Full textBaker, Danial E., and Kendra Demaris. "Defibrotide." Hospital Pharmacy 51, no. 10 (October 2016): 847–54. http://dx.doi.org/10.1310/hpj5110-847.
Full textTappe, William, Saurabh Aggarwal, Ozlem Topaloglu, and Massimo Iacobelli. "A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting." Clinical and Applied Thrombosis/Hemostasis 26 (January 1, 2020): 107602962093520. http://dx.doi.org/10.1177/1076029620935202.
Full textFareed, Jawed, Debra A. Hoppensteadt, Massimo Iacobelli, and Jeanine M. Walenga. "Defibrotide Does Not Cross-React with HIT Antibodies. Implications in the Management of HIT." Blood 108, no. 11 (November 16, 2006): 1054. http://dx.doi.org/10.1182/blood.v108.11.1054.1054.
Full textPark, Meerim, Hyeon Jin Park, Hyeon-Seok Eom, Jeong A. Park, Yeon Jung Lim, Jong Hyung Yoon, Hye Won Lee, Tak Yun, and Byung-Kiu Park. "Effects of Prophylactic Defibrotide for Veno-Occlusive Disease in Hematopoietic Stem Cell Transplantation." Blood 118, no. 21 (November 18, 2011): 4517. http://dx.doi.org/10.1182/blood.v118.21.4517.4517.
Full textFareed, Jawed, Debra Hoppensteadt, Omer Iqbal, Josephine Cunanan, Vinod Bansal, Schuharazad Abro, and Rakesh Wahi. "Defibrotide Interactions with Newer Oral Anticoagulants and Antithrombotic Agents." Blood 120, no. 21 (November 16, 2012): 3411. http://dx.doi.org/10.1182/blood.v120.21.3411.3411.
Full textFareed, Jawed, Adrian Sonevytsky, Omer Iqbal, Walter P. Jeske, Massimo Iacobelli, and Debra Hoppensteadt. "Inhibition of Heparinase I by Defibrotide with Potential Clinical Implications." Blood 108, no. 11 (November 16, 2006): 1626. http://dx.doi.org/10.1182/blood.v108.11.1626.1626.
Full textFareed, Jawed, Debra Hoppensteadt, Josephine Cunanan, Walter Jeske, Cafer Adiguzal, He Zhu, Cinara Echart, and Massimo Iacobelli. "Prolonged Administration of Defibrotide Is Non-Immunogenic in Rats and Dogs." Blood 114, no. 22 (November 20, 2009): 4180. http://dx.doi.org/10.1182/blood.v114.22.4180.4180.
Full textFareed, Jawed, Michael J. Moorman, Walter Jeske, and Debra Hoppensteadt. "Defibrotide Interaction With Newer Oral Anticoagulant and Antiplatelet Drugs." Blood 122, no. 21 (November 15, 2013): 4804. http://dx.doi.org/10.1182/blood.v122.21.4804.4804.
Full textFareed, Jawed, Omer Iqbal, Debra Hoppensteadt, Cafer Adiguzel, Massimo Iacobelli, and Jeanine M. Walenga. "Defibrotide Augments the Anticoagulant Actions of Heparin and Low Molecular Weight Heparins." Blood 112, no. 11 (November 16, 2008): 4086. http://dx.doi.org/10.1182/blood.v112.11.4086.4086.
Full textTappe, William, Saurabh Aggarwal, Ozlem Topaloglu, and Massimo Iacobelli. "A Meta-Analysis Evaluating the Risk of Bleeding-Related Adverse Events with Defibrotide Treatment." Blood 134, Supplement_1 (November 13, 2019): 2016. http://dx.doi.org/10.1182/blood-2019-123686.
Full textMaher, Kristin N., Xu Han, Keith B. Neeves, Marvin T. Nieman, and Jorge Di Paola. "Modulation of Thrombin-Induced Platelet Activation By Defibrotide." Blood 134, Supplement_1 (November 13, 2019): 3614. http://dx.doi.org/10.1182/blood-2019-125945.
Full textHasenkamp, Justin, Imme Conradi, Gerald Wulf, Wolfram Jung, Lorenz Truemper, and Bertram Glass. "Prevention of Veno-Occlusive Disease in Hematopoietic Stem Cell Transplantation Due to Defibrotide Prophylaxis." Blood 104, no. 11 (November 16, 2004): 1139. http://dx.doi.org/10.1182/blood.v104.11.1139.1139.
Full textRichardson, Paul G., Enric Carreras, Massimo Iacobelli, and Bijan Nejadnik. "The use of defibrotide in blood and marrow transplantation." Blood Advances 2, no. 12 (June 26, 2018): 1495–509. http://dx.doi.org/10.1182/bloodadvances.2017008375.
Full textTekgunduz, Emre, Seval Akpinar, Sinem Civriz Bozdag, Aysegul Tetik, Serife Kocubaba, Murat Cinarsoy, Gamze Durgun, et al. "Effectiveness of Defibrotide in the Prevention of VOD Among Patients Receiving Allogeneic Hematopoetic Cell Transplantation: A Retrospective Single Center Experience." Blood 120, no. 21 (November 16, 2012): 4508. http://dx.doi.org/10.1182/blood.v120.21.4508.4508.
Full textFareed, Jawed, Walter Jeske, Demetra Callas, Debra Hoppensteadt, and Jeanine Walenga. "Modulation of Endothelium by Heparin and Related Polyelectrolytes." Clinical and Applied Thrombosis/Hemostasis 2, no. 3 (July 1996): 200–208. http://dx.doi.org/10.1177/107602969600200310.
Full textMarubini, E., S. Coccheri, G. G. Nenci, and F. Violi. "Improvement of Walking Distance by Defibrotide in Patients with Intermittent Claudication." Thrombosis and Haemostasis 83, no. 05 (2000): 672–77. http://dx.doi.org/10.1055/s-0037-1613890.
Full textHale, Gregory A., Renee M. Madden, Kimberly A. Kasow, Joseph Woodard, Wing H. Leung, Raymond C. Barfield, Usman Yusuf, Edwin M. Horwitz, and Rupert Handgretinger. "High Dose Defibrotide as Therapy for Pediatric Patients with Veno-Occlusive Disease of the Liver." Blood 108, no. 11 (November 16, 2006): 2963. http://dx.doi.org/10.1182/blood.v108.11.2963.2963.
Full textMountfort, Katrina, Mohamad Mohty, and Elisabeth Wallhult. "Defibrotide – A New Treatment Approach for Severe Veno-occlusive Disease." European Oncology & Haematology 11, no. 1 (2015): 11. http://dx.doi.org/10.17925/eoh.2015.11.01.11.
Full textUygun, Vedat, Gulsun Tezcan, Volkan Hazar, and Akif Yesilipek. "Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease in Children." Blood 108, no. 11 (November 16, 2006): 5263. http://dx.doi.org/10.1182/blood.v108.11.5263.5263.
Full textRichardson, Paul G., Nancy A. Kernan, Stephan A. Grupp, Paul L. Martin, Robert J. Soiffer, Richard Martin, Alison L. Hannah, and Kathleen F. Villa. "Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival." Blood 124, no. 21 (December 6, 2014): 2469. http://dx.doi.org/10.1182/blood.v124.21.2469.2469.
Full textMarsili, M., P. Lorenzi, M. Librenti, L. Doni, C. Benassai, E. Martini, L. P. Fabbri, S. Cinotti, M. Morfini, and S. Boncinelli. "Defibrotide in Extracorporeal Circulation on Healthy Rabbits." International Journal of Artificial Organs 12, no. 12 (December 1989): 749–54. http://dx.doi.org/10.1177/039139888901201203.
Full textRuggieri, M., D. Vicini, P. Mirando, G. P. Franceschetti, C. Sali, G. L. Picchio, P. Marandola, and L. Cocilovo. "Physical treatment and physical-drugs treatment of induratio penis plastica: Orgotein versus defibrotide versus only physical treatment. Our experience." Urologia Journal 61, no. 4 (August 1994): 259–61. http://dx.doi.org/10.1177/039156039406100404.
Full textChalandon, Yves, Federico Simonetta, Carole Dantin, Aikaterini Koutsi, Anne-Claire Mamez, Yan Beauverd, Olga Tsopra, et al. "Efficient Prophylaxis with Defibrotide for Sinusoidal Obstruction Syndrome (SOS) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)." Blood 128, no. 22 (December 2, 2016): 2204. http://dx.doi.org/10.1182/blood.v128.22.2204.2204.
Full textEchart, Cinara L., Barbara Graziadio, Simona Somaini, Laura I. Ferro, Paul G. Richardson, Jawed Fareed, and Massimo Iacobelli. "The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity." Blood Coagulation & Fibrinolysis 20, no. 8 (December 2009): 627–34. http://dx.doi.org/10.1097/mbc.0b013e32832da1e3.
Full textPogliani, E. M., M. Salvatore, C. Fowst, R. Girardello, and C. Marelli. "Effects of a Defibrotide—Heparin Combination on Some Measures of Haemostasis in Healthy Volunteers." Journal of International Medical Research 17, no. 1 (January 1989): 36–40. http://dx.doi.org/10.1177/030006058901700105.
Full textCorbacioglu, Selim, Ansgar S. Schulz, Petr Sedlacek, Bernd Gruhn, Simone Cesaro, and Peter Bader. "Defibrotide for Prophylaxis of Hepatic Veno-Occlusive Disease in Pediatric Hematopoietic Stem Cell Transplantation: Subanalysis Data from an Open-Label, Phase III, Randomized Trial." Blood 126, no. 23 (December 3, 2015): 4310. http://dx.doi.org/10.1182/blood.v126.23.4310.4310.
Full textFilimberti, E., S. Cinotti, M. Salvadori, M. Amato, G. Longo, M. Nazzari, and M. Morfini. "Hemodialysis with Defibrotide: Effects on Coagulation Parameters." International Journal of Artificial Organs 15, no. 10 (October 1992): 590–94. http://dx.doi.org/10.1177/039139889201501004.
Full textKong, Seom Gim, Je-Hwan Lee, Young Tak Lim, Ji Hyun Lee, Hyeon-Seok Eom, Hyewon Lee, Do Young Kim, et al. "Influence of creatinine levels on survival in patients with veno-occlusive disease treated with defibrotide." Korean Journal of Internal Medicine 37, no. 1 (January 1, 2022): 179–89. http://dx.doi.org/10.3904/kjim.2021.178.
Full textLaurence, Jeffrey, and Sonia Elhadad. "Defibrotide Inhibits Endothelial Cell Injury Induced By Plasmas of Patients with Thrombotic Microangiopathies." Blood 134, Supplement_1 (November 13, 2019): 3676. http://dx.doi.org/10.1182/blood-2019-124158.
Full textBelcaro, G., and C. Marelli. "Treatment of Venous Lipodermatosclerosis and Ulceration in Venous Hypertension by Elastic Compression and Fibrinolytic Enhancement with Defibrotide." Phlebology: The Journal of Venous Disease 4, no. 2 (June 1989): 91–106. http://dx.doi.org/10.1177/026835558900400207.
Full text&NA;. "Walk further with defibrotide." Inpharma Weekly &NA;, no. 814 (November 1991): 14. http://dx.doi.org/10.2165/00128413-199108140-00039.
Full textFERRARESSO, MARIANO, PAOLO RIGOTTI, STANISLAW M. STEPKOWSKI, TING-CHAO CHOU, and BARRY D. KAHAN. "IMMUNOSUPPRESSIVE EFFECTS OF DEFIBROTIDE." Transplantation 56, no. 4 (October 1993): 928–33. http://dx.doi.org/10.1097/00007890-199310000-00029.
Full textBerti, F., F. Magni, and G. Rossoni. "Cardiovascular pharmacology of defibrotide." Pharmacological Research Communications 20 (September 1988): 37. http://dx.doi.org/10.1016/s0031-6989(88)80167-x.
Full textArtesani, M. C. "Anaphylactic shock to defibrotide." Allergy 61, no. 8 (August 2006): 1022. http://dx.doi.org/10.1111/j.1398-9995.2006.01086.x.
Full textRichardson, Paul G., Angela R. Smith, Brandon M. Triplett, Nancy A. Kernan, Stephan A. Grupp, Sally Arai, Joseph H. Antin, et al. "Updated Results from a Large, Ongoing, Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease." Blood 124, no. 21 (December 6, 2014): 2470. http://dx.doi.org/10.1182/blood.v124.21.2470.2470.
Full textRichardson, Paul, Enric Carreras, Antonio Pagliuca, Robert Ryan, William Tappe, and Mohamad Mohty. "A Pooled Analysis of Survival By Defibrotide Timing of Initiation in Adults with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Following Hematopoietic Stem Cell Transplant (HSCT)." Blood 132, Supplement 1 (November 29, 2018): 815. http://dx.doi.org/10.1182/blood-2018-99-113099.
Full textUnal, Emel, Nurdan Tacyildiz, Gulsan Yavuz, Handan Dincaslan, Gulsah Tanyildiz, Erol Ayyildiz, and Muhit Ozcan. "Defibrotide for Prophylaxis of Hepatic Veno-Occlusive Disease in Autologous, Non-Purged Peripheral Stem Cell Transplantation for High Risk Neuroblastoma Patients." Blood 124, no. 21 (December 6, 2014): 5910. http://dx.doi.org/10.1182/blood.v124.21.5910.5910.
Full textMilone, G., M. Poidomani, S. Coppoletta, E. Mauro, E. Marturano, F. Crispi, A. Spadaro, A. Di Marco, and S. Leotta. "Defibrotide in Prevention of Liver Toxicity in Patients at High Risk of VOD after HSC Transplantation." Blood 112, no. 11 (November 16, 2008): 3275. http://dx.doi.org/10.1182/blood.v112.11.3275.3275.
Full textDignan, Fiona L., Dorothy Gujral, Mark E. Ethell, Jennifer Treleaven, Gareth Morgan, and Michael Potter. "Prophylactic Defibrotide in Allogeneic Stem Cell Transplantation: Low Morbidity and Zero Mortality from Veno-Occlusive Disease." Blood 108, no. 11 (November 16, 2006): 2968. http://dx.doi.org/10.1182/blood.v108.11.2968.2968.
Full textPescador, Rodolfo, Roberto Porta, and Laura Ferro. "Defibrotide and Endothelial Cell Activation." Cardiovascular Drug Reviews 18, no. 4 (June 7, 2006): 304–11. http://dx.doi.org/10.1111/j.1527-3466.2000.tb00054.x.
Full text&NA;. "Defibrotide has benefits in AMI." Inpharma Weekly &NA;, no. 723 (February 1990): 8. http://dx.doi.org/10.2165/00128413-199007230-00019.
Full textRichardson, Paul G., Selim Corbacioglu, Vincent Trien-Vinh Ho, Nancy A. Kernan, Leslie Lehmann, Craig Maguire, Michelle Maglio, et al. "Drug safety evaluation of defibrotide." Expert Opinion on Drug Safety 12, no. 1 (December 10, 2012): 123–36. http://dx.doi.org/10.1517/14740338.2012.749855.
Full textLazarus, Hillard M., and Keith R. McCrae. "SOS! Defibrotide to the rescue." Blood 112, no. 10 (November 15, 2008): 3924–25. http://dx.doi.org/10.1182/blood-2008-09-177246.
Full textZhou, Quansheng, Xiaohong Chu, and Changgeng Ruan. "Defibrotide Stimulates Expression of Thrombomodulin in Human Endothelial Cells." Thrombosis and Haemostasis 71, no. 04 (1994): 507–10. http://dx.doi.org/10.1055/s-0038-1642468.
Full text